Deciphera Pharmaceuticals, Inc. Comprehensive Income
Deciphera Pharmaceuticals, Inc. reported Comprehensive Income of -$45.56 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2024-05-10
- Deciphera Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-03-31 was -$45.56M.
- Deciphera Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-12-31 was -$45.72M.
- Deciphera Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-09-30 was -$49.51M.
- Deciphera Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-06-30 was -$49.35M.
- Deciphera Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$193.38M.
- Deciphera Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$179.97M.
- Deciphera Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$299.92M.
- Deciphera Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$266.59M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2024-03-31 | -$45.56M 10-Q · filed 2024-05-10 | -$91.28M derived: sum of 2 quarters · filed 2024-05-10 | -$140.79M derived: sum of 3 quarters · filed 2024-05-10 | -$190.14M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-12-31 | -$45.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | -$95.23M derived: sum of 2 quarters · filed 2024-02-07 | -$144.57M derived: sum of 3 quarters · filed 2024-02-07 | -$193.38M 10-K · filed 2024-02-07 |
| 2023-09-30 | -$49.51M 10-Q · filed 2023-10-30 | -$98.86M derived: sum of 2 quarters · filed 2023-10-30 | -$147.66M 10-Q · filed 2023-10-30 | -$192.54M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-06-30 | -$49.35M 10-Q · filed 2023-08-09 | -$98.16M 10-Q · filed 2023-08-09 | -$143.03M derived: sum of 3 quarters · filed 2024-05-10 | -$186.85M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-03-31 | -$48.81M 10-Q · filed 2024-05-10 | -$93.68M derived: sum of 2 quarters · filed 2024-05-10 | -$137.50M derived: sum of 3 quarters · filed 2024-05-10 | -$181.27M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$44.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | -$88.69M derived: sum of 2 quarters · filed 2024-02-07 | -$132.46M derived: sum of 3 quarters · filed 2024-02-07 | -$179.97M 10-K · filed 2024-02-07 |
| 2022-09-30 | -$43.82M 10-Q · filed 2023-10-30 | -$87.58M derived: sum of 2 quarters · filed 2023-10-30 | -$135.09M 10-Q · filed 2023-10-30 | -$223.60M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | -$43.77M 10-Q · filed 2023-08-09 | -$91.27M 10-Q · filed 2023-08-09 | -$179.78M derived: sum of 3 quarters · filed 2024-02-07 | -$259.48M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | -$47.51M 10-Q · filed 2023-05-03 | -$136.01M derived: sum of 2 quarters · filed 2024-02-07 | -$215.71M derived: sum of 3 quarters · filed 2024-02-07 | -$286.16M derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | -$88.51M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | -$168.21M derived: sum of 2 quarters · filed 2024-02-07 | -$238.66M derived: sum of 3 quarters · filed 2024-02-07 | -$299.92M 10-K · filed 2024-02-07 |
| 2021-09-30 | -$79.70M 10-Q · filed 2022-11-03 | -$150.15M derived: sum of 2 quarters · filed 2022-11-03 | -$211.41M 10-Q · filed 2022-11-03 | -$274.18M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | -$70.45M 10-Q · filed 2022-08-04 | -$131.72M 10-Q · filed 2022-08-04 | -$194.48M derived: sum of 3 quarters · filed 2023-02-07 | -$258.14M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | -$61.27M 10-Q · filed 2022-05-04 | -$124.03M derived: sum of 2 quarters · filed 2023-02-07 | -$187.69M derived: sum of 3 quarters · filed 2023-02-07 | -$255.70M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | -$62.77M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | -$126.42M derived: sum of 2 quarters · filed 2023-02-07 | -$194.43M derived: sum of 3 quarters · filed 2023-02-07 | -$266.59M 10-K · filed 2023-02-07 |
| 2020-09-30 | -$63.65M 10-Q · filed 2021-11-02 | -$131.67M derived: sum of 2 quarters · filed 2021-11-02 | -$203.82M 10-Q · filed 2021-11-02 | -$270.99M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-06-30 | -$68.01M 10-Q · filed 2021-08-03 | -$140.17M 10-Q · filed 2021-08-03 | -$207.33M derived: sum of 3 quarters · filed 2022-02-08 | -$263.64M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-03-31 | -$72.16M 10-Q · filed 2021-05-04 | -$139.32M derived: sum of 2 quarters · filed 2022-02-08 | -$195.63M derived: sum of 3 quarters · filed 2022-02-08 | -$216.94M derived: sum of 4 quarters · filed 2022-02-08 |
| 2019-12-31 | -$67.17M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | -$123.48M derived: sum of 2 quarters · filed 2022-02-08 | -$144.78M derived: sum of 3 quarters · filed 2022-02-08 | -$192.15M 10-K · filed 2022-02-08 |
| 2019-09-30 | -$56.31M 10-Q · filed 2020-11-05 | -$77.62M derived: sum of 2 quarters · filed 2020-11-05 | -$124.98M 10-Q · filed 2020-11-05 | -$157.28M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | -$21.31M 10-Q · filed 2020-08-04 | -$68.67M 10-Q · filed 2020-08-04 | -$100.97M derived: sum of 3 quarters · filed 2021-02-09 | -$125.40M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | -$47.36M 10-Q · filed 2020-05-05 | -$79.66M derived: sum of 2 quarters · filed 2021-02-09 | -$104.10M derived: sum of 3 quarters · filed 2021-02-09 | -$125.79M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | -$32.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | -$56.73M derived: sum of 2 quarters · filed 2021-02-09 | -$78.42M derived: sum of 3 quarters · filed 2021-02-09 | -$99.85M 10-K · filed 2021-02-09 |
| 2018-09-30 | -$24.43M 10-Q · filed 2019-11-04 | -$46.13M derived: sum of 2 quarters · filed 2019-11-04 | -$67.56M 10-Q · filed 2019-11-04 | |
| 2018-06-30 | -$21.69M 10-Q · filed 2019-08-02 | -$43.12M 10-Q · filed 2019-08-02 | ||
| 2018-03-31 | -$21.43M 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | -$50.28M 10-K · filed 2020-03-09 |